Literature DB >> 21248832

AIDS: Drugs that prevent HIV infection.

Mark A Wainberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21248832     DOI： 10.1038/469306a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  11 in total

1.  Could chemoprophylaxis be used as an HIV prevention strategy while we wait for an effective vaccine?

Authors:  Mike Youle; Mark A Wainberg
Journal:  AIDS       Date:  2003-04-11       Impact factor: 4.177

2.  Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women.

Authors:  Quarraisha Abdool Karim; Salim S Abdool Karim; Janet A Frohlich; Anneke C Grobler; Cheryl Baxter; Leila E Mansoor; Ayesha B M Kharsany; Sengeziwe Sibeko; Koleka P Mlisana; Zaheen Omar; Tanuja N Gengiah; Silvia Maarschalk; Natasha Arulappan; Mukelisiwe Mlotshwa; Lynn Morris; Douglas Taylor
Journal:  Science       Date:  2010-07-19       Impact factor: 47.728

3.  Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice.

Authors:  K M De Cock; M G Fowler; E Mercier; I de Vincenzi; J Saba; E Hoff; D J Alnwick; M Rogers; N Shaffer
Journal:  JAMA       Date:  2000-03-01       Impact factor: 56.272

4.  Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.

Authors:  Robert M Grant; Javier R Lama; Peter L Anderson; Vanessa McMahan; Albert Y Liu; Lorena Vargas; Pedro Goicochea; Martín Casapía; Juan Vicente Guanira-Carranza; Maria E Ramirez-Cardich; Orlando Montoya-Herrera; Telmo Fernández; Valdilea G Veloso; Susan P Buchbinder; Suwat Chariyalertsak; Mauro Schechter; Linda-Gail Bekker; Kenneth H Mayer; Esper Georges Kallás; K Rivet Amico; Kathleen Mulligan; Lane R Bushman; Robert J Hance; Carmela Ganoza; Patricia Defechereux; Brian Postle; Furong Wang; J Jeff McConnell; Jia-Hua Zheng; Jeanny Lee; James F Rooney; Howard S Jaffe; Ana I Martinez; David N Burns; David V Glidden
Journal:  N Engl J Med       Date:  2010-11-23       Impact factor: 91.245

5.  Two low doses of tenofovir protect newborn macaques against oral simian immunodeficiency virus infection.

Authors:  K K Van Rompay; M B McChesney; N L Aguirre; K A Schmidt; N Bischofberger; M L Marthas
Journal:  J Infect Dis       Date:  2001-07-16       Impact factor: 5.226

6.  Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group.

Authors:  T C Quinn; M J Wawer; N Sewankambo; D Serwadda; C Li; F Wabwire-Mangen; M O Meehan; T Lutalo; R H Gray
Journal:  N Engl J Med       Date:  2000-03-30       Impact factor: 91.245

7.  Intermittent prophylaxis with oral truvada protects macaques from rectal SHIV infection.

Authors:  J Gerardo García-Lerma; Mian-er Cong; James Mitchell; Ae S Youngpairoj; Qi Zheng; Silvina Masciotra; Amy Martin; Zsuzsanna Kuklenyik; Angela Holder; Jonathan Lipscomb; Chou-Pong Pau; John R Barr; Debra L Hanson; Ron Otten; Lynn Paxton; Thomas M Folks; Walid Heneine
Journal:  Sci Transl Med       Date:  2010-01-13       Impact factor: 17.956

8.  Role of HIV Subtype Diversity in the Development of Resistance to Antiviral Drugs.

Authors:  Mark A Wainberg; Bluma G Brenner
Journal:  Viruses       Date:  2010-11-11       Impact factor: 5.048

9.  Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial.

Authors:  Bertran Auvert; Dirk Taljaard; Emmanuel Lagarde; Joëlle Sobngwi-Tambekou; Rémi Sitta; Adrian Puren
Journal:  PLoS Med       Date:  2005-10-25       Impact factor: 11.069

10.  Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovir.

Authors:  J Gerardo García-Lerma; Ron A Otten; Shoukat H Qari; Eddie Jackson; Mian-Er Cong; Silvina Masciotra; Wei Luo; Caryn Kim; Debra R Adams; Michael Monsour; Jonathan Lipscomb; Jeffrey A Johnson; David Delinsky; Raymond F Schinazi; Robert Janssen; Thomas M Folks; Walid Heneine
Journal:  PLoS Med       Date:  2008-02       Impact factor: 11.069
View more
  9 in total

1.  Macaque studies of vaccine and microbicide combinations for preventing HIV-1 sexual transmission.

Authors:  Dan H Barouch; Per Johan Klasse; Jason Dufour; Ronald S Veazey; John P Moore
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-14       Impact factor: 11.205

2.  Endosomal trafficking of nanoformulated antiretroviral therapy facilitates drug particle carriage and HIV clearance.

Authors:  Dongwei Guo; Gang Zhang; Tadeusz A Wysocki; Beata J Wysocki; Harris A Gelbard; Xin-Ming Liu; JoEllyn M McMillan; Howard E Gendelman
Journal:  J Virol       Date:  2014-06-11       Impact factor: 5.103

3.  Small magnetite antiretroviral therapeutic nanoparticle probes for MRI of drug biodistribution.

Authors:  Dongwei Guo; Tianyuzi Li; JoEllyn McMillan; Balasrinivasa R Sajja; Pavan Puligujja; Michael D Boska; Howard E Gendelman; Xin-Ming Liu
Journal:  Nanomedicine (Lond)       Date:  2013-08-01       Impact factor: 5.307

4.  Nuclear receptor signaling inhibits HIV-1 replication in macrophages through multiple trans-repression mechanisms.

Authors:  Timothy M Hanley; Gregory A Viglianti
Journal:  J Virol       Date:  2011-08-17       Impact factor: 5.103

5.  Detectable signals of episodic risk effects on acute HIV transmission: strategies for analyzing transmission systems using genetic data.

Authors:  Shah Jamal Alam; Xinyu Zhang; Ethan Obie Romero-Severson; Christopher Henry; Lin Zhong; Erik M Volz; Bluma G Brenner; James S Koopman
Journal:  Epidemics       Date:  2012-11-23       Impact factor: 4.396

Review 6.  Blocking HIV-1 transmission in the female reproductive tract: from microbicide development to exploring local antiviral responses.

Authors:  Sahar G Eid; Niamh E Mangan; Paul J Hertzog; Johnson Mak
Journal:  Clin Transl Immunology       Date:  2015-10-09

7.  Quality by Design Optimization of Cold Sonochemical Synthesis of Zidovudine-Lamivudine Nanosuspensions.

Authors:  Bwalya A Witika; Vincent J Smith; Roderick B Walker
Journal:  Pharmaceutics       Date:  2020-04-17       Impact factor: 6.321

8.  Intracellular immunization against HIV infection with an intracellular antibody that mimics HIV integrase binding to the cellular LEDGF protein.

Authors:  Leyuan Bao; Clare Hannon; Abimael Cruz-Mignoni; Denis Ptchelkine; Mei-Yi Sun; Ami Miller; Wilawan Bunjobpol; Camilo E Quevedo; Mariliza Derveni; Jennifer Chambers; Alison Simmons; Simon E V Phillips; Terence H Rabbitts
Journal:  Sci Rep       Date:  2017-12-04       Impact factor: 4.379

9.  Combining New Non-Nucleoside Reverse Transcriptase Inhibitors (RTIs) with AZT Results in Strong Synergism against Multi-RTI-Resistant HIV-1 Strains.

Authors:  Fei Yu; Wen Li; Lili Wang; Yu Dai; Xin Lu; Qian Wang; Lan Xie; Shibo Jiang
Journal:  Molecules       Date:  2018-07-02       Impact factor: 4.411
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.